$KMB — AVOID 📊

$KMB — AVOID 📊 Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. 🎯 Q1 FY26 | Rev $4B | EPS $1.97 vs $1.93 🟢 💡 Consensus may view the EPS beat as confirmation of resilience, but market-implied expectations for sustained premium valuation are too high given modest organic growth and no guidance raise. 📉 Reward/Risk: 0.62:1 🏢 Business Quality: 8/10 📊 Valuation: rich - based on PE of 19.7x vs 15-year historical range of 15.6-18.2x and median 15.9x; the current multiple sits at the 157th percentile, indicating... 🔮 Catalyst: No immediate positive event; next meaningful catalyst is Q2 2026 earnings in 3 months 💰 Entry: $104.28, stop $95, target $110 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/KMB0617 Also in play: $SBSW $AG $HL $CDE $PAAS

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States.